Jiangxi Sanxin Medtec Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangxi Sanxin Medical Technology Co., Ltd., stock code: 300453, founded in 1997, is a national high-tech enterprise specializing in the research and development, manufacturing, sales, and service of medical devices. After more than 20 years of accumulation and development, the company has adopted a global perspective, closely followed national development strategies, and closely met clinical needs. Relying on a sound quality management system and mature research and development, manufacturing advantages, the company has taken the lead in passing CE, CMD quality management system and product certification in the industry, as well as FDA (510K) listing permit in the United States. Progressive innovation and pursuit of excellence have developed into a listed company in the entire industry chain solution for blood purification in China. It is also the first and only listed company in the medical device industry in Jiangxi Province to date. For more than 20 years, Sanxin Medical has continuously optimized its product structure and successfully transformed and upgraded from the traditional infusion field, becoming one of the few listed companies in China that can provide full industry chain solutions for blood purification. The company has provided over 120 million dialysis services and over 800 million vaccine vaccinations to the Centers for Disease Control and Prevention. It currently has over 80 patent certificates and product registration certificates, and has participated in the formulation of 10 national and industry standards. Its products are exported to over 60 countries and regions. The company actively explores a new pattern of industrial development and has established a national development layout centered around its headquarters in Jiangxi. Its main products include six series: blood purification, indwelling catheters, injections, infusion and transfusion, cardiothoracic surgery, and protection. |
| Headquarter | Nanchang |
| Establish Date | 3/7/1997 |
| Listed Code | 300453.SZ |
| Listed Date | 5/15/2015 |
| Chairman | Peng Yixing. |
| CEO | Mao Zhiping. |
| Website | www.sanxin-med.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
